Point

Naproxen Sodium

Method of action: Analgesic, Anti-Inflammatory, Antipyretic, Antirheumatic, Nonsteroidal Anti-Inflammatory, Pain Reliever

Treatment option: Ankylosing Spondylitis, Arthritis,Osteoarthritis, Pain, Bursitis, Headache, Dysmenorrhea, Toothache, Migraine, Neuralgia, Osteoarthritis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Point

Quick Facts

Property	Description
Active Ingredient	Naproxen Sodium
Form	Oral Solid Forms (e.g., Tablet, Capsule)
Pharmacological Class	Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose	Relief from pain, inflammation, and fever
Origin	Synthetic

What is Point: Definition and Pharmacological Class

Point is a medicinal product containing the active ingredient Naproxen Sodium and is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This drug is a synthetic, single-ingredient compound used broadly to address pain, inflammation, and fever across the body.

The classification of Point as an NSAID places it within a core group of medications defined by their capacity to interfere with the chemical pathways that initiate pain and swelling. The drug's therapeutic actions are derived entirely from the Naproxen Sodium component, which is the salt form of the acid Naproxen. This component functions to relieve pain from various conditions. This particular formulation, Naproxen Sodium, is commonly recognized for providing pain relief that can last up to 12 hours. While chemically related to other NSAIDs, Naproxen is structurally characterized by this long duration of effect, often requiring less frequent dosing than comparable agents.

Composition and Available Forms of Naproxen Sodium

The composition of Point centers on the orally administered Naproxen Sodium, which is delivered using inert pharmaceutical excipients in various physical structures. This single-active-ingredient medicine is primarily available in several oral solid forms, including standard immediate-release tablets, as well as specialized enteric-coated tablets and extended-release tablets.

These different oral dosage forms—which may also include an oral suspension—allow the medicine to be tailored to specific absorption needs. For instance, the enteric-coated tablet is specifically designed to delay the release of the drug until it bypasses the stomach. The extended-release tablet is structurally formulated to provide a sustained level of the active component over a longer period, an aspect clinically recognized for improving compliance.

General Benefit and Core Physiological Action

The general benefit of Point is to deliver analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) relief simultaneously. This triple action is the primary function of the drug, as defined by its core mechanism.

The drug achieves this by fundamentally acting on the body's inflammatory response, specifically by modulating the production of chemical mediators known as prostaglandins. NSAIDs act primarily by inhibiting the cyclooxygenase enzymes responsible for synthesizing prostaglandins. By limiting the creation of prostaglandins, the medicine provides comprehensive relief, such as easing the physical discomfort and swelling that accompanies acute soft-tissue injury, defining its high-level therapeutic purpose.

What side effects are possible with Point?

Possible Side Effects and Safety Information

Like all medications, vonoprazan (Point) can cause side effects, although not everyone experiences them. Most side effects are mild and related to the gastrointestinal system.

Common Side Effects

Gastrointestinal: Diarrhea, constipation, abdominal pain, nausea, bloating, indigestion, and altered sense of taste.
Other: Headache, and increased risk of upper respiratory tract infection (e.g., common cold) or urinary tract infection (UTI).

Serious Side Effects

While rare, some side effects may be serious and require immediate medical attention. Contact your healthcare provider right away if you experience any of the following:

System	Possible Serious Side Effect
Allergic/Skin	Severe allergic reaction (hives, swelling of the face/throat, difficulty breathing), or severe skin reactions (e.g., Stevens-Johnson syndrome) that cause a rash with blistering, peeling, or sores.
Gastrointestinal	Clostridioides difficile-associated diarrhea (persistent, severe, watery, or bloody diarrhea).
Kidney	Signs of kidney problems, such as sudden decrease in urination, blood in the urine, fever, or swelling of the body/ankles.
Electrolyte/Nutrient	Symptoms of low magnesium (seizures, irregular heartbeat, muscle cramps) or low vitamin B12 (unusual tiredness, pale skin, numbness, or tingling).

Long-Term Safety Concerns

Long-term or high-dose use of acid-reducing medications, including vonoprazan, may be associated with an increased risk of:

Bone Fractures: Fractures of the hip, wrist, or spine, particularly in older adults.
Fundic Gland Polyps: Small growths on the lining of the stomach. These are usually benign (non-cancerous).

It is important to use vonoprazan for the shortest duration necessary to treat your condition. Always discuss your complete medical history and all current medications with your doctor, as this drug may affect or be affected by other treatments.

Overdose and Emergency Response

Overdose with Point (Naproxen Sodium), an NSAID, requires immediate medical attention. Official regulatory guidance mandates seeking emergency help or contacting a Poison Control Center right away, as serious outcomes may develop even if initial symptoms appear mild. Hospital monitoring is required for several hours following acute overdose.

Documented manifestations of overdose in regulatory labeling include gastrointestinal effects like nausea, vomiting, heartburn, and abdominal pain. Central nervous system signs may involve drowsiness, dizziness, vertigo, or tinnitus. Severe, life-threatening outcomes formally described are gastrointestinal bleeding, seizures (convulsions), coma, respiratory depression, and acute renal failure.

There is no specific antidote known for Naproxen overdose. Management is therefore defined as symptomatic and supportive treatment. Supportive measures documented in labeling may include the use of activated charcoal or gastric lavage for recent, substantial ingestions. Monitoring of renal and hepatic function is required during observation. Regulatory documents also note that elderly patients and those with impaired renal function may be more susceptible to serious toxicity.

Therapeutic Uses of Point

What Point Treats: Main Uses and Benefits

The primary therapeutic benefit of Point (Naproxen Sodium) is to offer symptomatic support across conditions where symptoms create noticeable interference with daily functioning. It is applied when symptom clusters require supportive management and temporary functional assistance. The therapeutic uses are established for addressing symptoms across various conditions.

Key Therapeutic Applications

This medication is commonly used to support the management of persistent symptoms associated with conditions involving inflammatory or irritative processes, such as Rheumatoid Arthritis and Osteoarthritis. It is used for managing symptoms related to enduring joint pain, swelling, and stiffness, which generally contributes to improved day-to-day comfort and assists with maintaining functional stability.

Point is also relevant for acute, episodic pain flares. Common indications include managing pain from conditions like Tendinitis, Bursitis, Primary Dysmenorrhea (menstrual cramps), acute gout, and the pain and swelling following soft-tissue injuries or procedures. It provides supportive relief when symptoms interfere with routine activities.

“It helps address symptom clusters that may become intense or disruptive, supporting general well-being during symptomatic phases.”

Systemic and Local Symptom Relief

In clinical settings marked by the presence of systemic symptoms, Point is commonly used to help with fever and associated body aches during common illnesses, primarily relevant for addressing fever. This contributes to easing the overall symptomatic burden. It is applied across domains where short-term symptom management is appropriate, and may assist in maintaining routine comfort when symptoms are more noticeable.

Quick Fact	Relief for
Symptomatic Support	Chronic joint stiffness and pain (e.g., in RA and OA)
Relief for Acute Flares	Sudden, severe discomfort (e.g., Acute Gout, Migraine, Dysmenorrhea)
Post-Injury/Systemic Relief	Swelling, localized pain, and fever

Regulatory References

DailyMed overview of Naproxen Sodium uses

Eligibility and Restrictions for Use

Who Can and Cannot Use Point: Official Regulatory Information

Eligibility for Point (Naproxen Sodium) is strictly defined by regulatory authorities based on age, specific medical history, and physiological status.

Absolute Contraindications

Use is prohibited for patients with a known hypersensitivity to naproxen, or a history of allergic reactions (e.g., asthma, urticaria) after taking aspirin or any other NSAID. The medicine is also contraindicated for women beginning at 30 weeks gestation (third trimester) and in the setting of Coronary Artery Bypass Graft (CABG) surgery. Absolute contraindications further include severe uncontrolled heart failure, advanced renal disease, severe hepatic failure, or active gastrointestinal bleeding/ulceration.

Age and Conditional Restrictions

Population Group	Regulatory Status	Status Context
Pediatric Patients	Not Established / Restricted	Safety and effectiveness are not established for all uses in children under 2 years.
Older Adults (65+)	Conditional Use	Requires close monitoring; the lowest effective dose for the shortest duration is generally advised.
Pregnancy	Contraindicated / Avoid Use	Contraindicated from 30 weeks gestation; avoidance is recommended from 20 weeks onward.
Organ Impairment	Conditional Use	Use with caution in mild-to-moderate renal or hepatic impairment and in patients with hypertension or cardiovascular risk factors.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Naproxen Sodium (Point) is officially documented by regulatory authorities, focusing on pharmacokinetic alterations and additive pharmacodynamic risks. This information establishes necessary restrictions and classifications for co-administration with other substances.

Formal Restrictions and Classification

Classification	Interacting Substance/Condition
Contraindicated	Co-administration with other NSAIDs (including naproxen-containing products)
Contraindicated	Peri-operative pain management related to CABG surgery
Timing Rule	Mifepristone (must not be used for 8 to 12 days post-administration)

Officially Documented Interactions

Co-administration with Anticoagulants (e.g., Warfarin) and other anti-platelet agents carries an official warning for a significantly increased risk of bleeding. Naproxen Sodium may also inhibit the clearance of specific medicines, leading to increased plasma concentrations of drugs such as Lithium and Digoxin. The combination with ACE Inhibitors and Diuretics may diminish the therapeutic effect of these medicines. Concomitant systemic use with Corticosteroids is associated with an increased risk of gastrointestinal ulceration. Furthermore, official documentation notes that consumption of three or more alcoholic drinks daily while taking Naproxen Sodium may increase the risk of gastrointestinal bleeding. Regulatory documents also cite the interaction with ACE Inhibitors/ARBs as having specific heightened relevance in the elderly or those with renal impairment, potentially leading to deterioration of renal function.

Mechanism of Action

The function of Point (Naproxen Sodium) is to interrupt biochemical processes via targeted enzyme inhibition. The drug acts by non-selectively inhibiting enzymes within the arachidonic acid cascade.

Targeting the Cyclooxygenase Enzymes

The drug’s mechanism is initiated at the molecular level by reversibly binding to and inhibiting both the Cyclooxygenase-1 ( COX-1) and Cyclooxygenase-2 ( COX-2) enzymes. This inhibition prevents the catalytic conversion of arachidonic acid into prostaglandins and thromboxanes, which are chemical mediators in physiological processes.

Modulating Nociception and Thermoregulation Signaling

By suppressing the synthesis of prostaglandins, the drug alters signaling dynamics in peripheral nociception and central thermoregulation. The reduced presence of these mediators modifies the chemical sensitivity of nociceptors and modulates the hypothalamic set-point for core body temperature, resulting in specific alterations to physiological signaling.

Constraints of the Enzyme-Mediated Mechanism

The mechanism is strictly dependent on the cyclooxygenase pathway. Its mechanism is less relevant in physiological states not mediated by prostaglandins, such as pure neuropathic pain. This dependency defines the biological scope of this enzyme-inhibition mechanism.

Dosage and Administration Information

How to Use Point (Naproxen Sodium): Administration Overview

Point is administered exclusively via the oral route, available in multiple solid forms, including immediate-release, controlled-release, and delayed-release tablets. The general principle is to use the lowest effective dose for the shortest duration necessary to manage symptoms.

Dosing is structured based on the condition. For long-term management of conditions like Osteoarthritis, the standard range is typically 500 mg to 1000 mg total daily dose, often administered in divided doses. This amount may be temporarily increased up to 1500 mg daily for limited periods under clinical supervision. Conversely, the regimen for acute conditions such as gout or pain begins with a higher initial loading dose, followed by a reduced, more frequent maintenance schedule.

The frequency varies with the formulation: controlled-release tablets are generally taken once daily, while immediate-release forms are typically dosed twice daily (every 12 hours). A key procedural condition is that specialized solid forms, such as delayed-release and controlled-release tablets, must not be crushed, broken, or chewed to preserve the integrity of their designed drug-release characteristics.

Administration must be contextualized around meals; all oral forms should be taken with or immediately after food and with a full glass of water to optimize gastrointestinal tolerance. Dosage adjustments are utilized for specific populations. The use in older adults necessitates utilizing the lowest possible effective dose, and for approved pediatric indications (e.g., Juvenile Idiopathic Arthritis), the dosage is weight-based (approximately 10 mg/kg daily). These detailed rules define the standardized protocol for administering Point.

Recent Clinical Evidence

Evidence for Managing Chronic Inflammatory Joint Conditions

Point (Naproxen Sodium) was evaluated in research exploring conditions associated with symptoms that may impact daily activities, particularly Rheumatoid Arthritis (RA) and Osteoarthritis (OA). Research examined how symptoms change over time in these settings. The body of evidence includes controlled trials and systematic reviews involving adults with active, symptomatic manifestations. These trials were primarily applied in studies examining patient-reported experiences of pain and stiffness, with follow-up durations ranging from short-term (a few weeks) to intermediate-term (several months).

Studies monitored patient assessments of pain intensity and the extent of morning stiffness in RA populations. Similarly, studies in OA described patterns observed in the measured outcomes related to daily functioning, such as walking ability and the overall perceived discomfort of the affected joints. Research provides context related to how patients reported their experience when Naproxen Sodium was observed in settings of chronic joint pain.

However, the existing research is largely focused on outcomes related to physical discomfort and temporary changes in functioning. Limited information is available for long-term outcomes, particularly regarding how Naproxen Sodium was studied relative to treatments designed to modify or slow the progression of the underlying joint disease. The evidence structure is relevant in trials assessing short-term or episodic symptom patterns within the context of a chronic condition.

Studies Evaluating Joint Pain and Function

Studies have monitored metrics such as the American College of Rheumatology (ACR) criteria in RA and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores in OA. These patient-reported outcomes describing perceived discomfort were evaluated in large research groups. Research has explored daily functioning or activity level.

Evidence for Acute Pain and Symptomatic Flares

Naproxen Sodium has also been evaluated in research exploring short-term symptom changes in conditions associated with acute or disruptive episodes, such as Primary Dysmenorrhea, Acute Gout, and Tendinitis/Bursitis. This evidence is relevant in trials assessing short-term or episodic symptom patterns, with typical follow-up periods spanning only a few days or weeks. For acute gout, studies documented the changes measured during the study period related to the observed changes in acute pain and inflammation in the affected joint.

Research Gaps and What Remains Uncertain

While research has explored the acute effects of Naproxen Sodium, data for certain groups remain insufficient. For instance, the outcomes for very older adults or for those with complex comorbidities are often not the primary focus of the research. Long-term effects are not fully established for predicting individual, sustained responses over many years of potential use.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Point (FAQ)

Q: Does Point (Naproxen Sodium) treat my condition, or just the symptoms?

Point (Naproxen Sodium) is classified as a medicine that provides relief from symptoms, such as pain, inflammation, and stiffness. The body of evidence indicates that the drug is not designed to modify or slow the underlying disease progression of conditions like arthritis. Its primary action is focused on alleviating the immediate physical symptoms.

Q: What should I do if I forget to take a dose of Point?

Official guidance states that if a dose is missed, it can be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped instead. Official guidance indicates that a double dose should not be taken to make up for a missed one.

Q: Which specific forms of Point should I not crush or chew?

To preserve the intended drug release, regulatory information mandates that specialized solid forms, such as controlled-release or delayed-release tablets, are to be swallowed whole. Standard immediate-release tablets are generally taken orally as is, but it is important to always follow the specific instructions for the product form you receive.

Q: What are the signs of a serious allergic reaction to Point?

According to official product information, signs of a serious allergic reaction may include difficulty breathing or swallowing, hoarseness, and swelling of the face, throat, tongue, or lips. Skin reactions such as hives, a rash, or blistering may also occur. These symptoms require immediate medical attention.

Q: Can I use Naproxen Sodium for a headache?

Official labeling for Naproxen Sodium includes the relief of mild to moderate pain as a primary indication. The official labeling supports its use for pain relief. Consultation with a healthcare provider is necessary to determine if it is appropriate for a specific condition.

Q: What is the maximum daily dose for acute pain or gout?

For the initial day of treatment for acute pain states, official dosing guides indicate that a maximum total daily dose is set. This dosage is typically higher on the first day to begin relief, and is then reduced for the remaining treatment period. Consult a healthcare provider for your specific prescribed dosing schedule.

Q: How long does it take for Point to start working?

Studies on the way the body handles Point (pharmacokinetics) indicate that for immediate-release tablets, the highest level of the medicine in the blood is generally reached within one to two hours. This timeframe indicates when the drug may become available in the body to help relieve symptoms.

How should Point be stored and disposed of?

How to Store and Dispose of Point (Naproxen Sodium)

Official regulatory guidelines define specific conditions for storing and discarding Point to maintain its stability and prevent unauthorized access.

Official Storage Conditions

Requirement	Specific Rule
Temperature	Store at controlled room temperature, typically 20 C to 25 C.
Protection	Keep the product protected from light, excessive heat, and high humidity.
Packaging	Keep the medicine in its original, well-closed container or carton.
Child Safety	Store medication strictly out of the sight and reach of children.

Disposal Requirements

Regulatory agencies recommend using a drug take-back program (e.g., at a pharmacy or authorized collector) as the preferred method for discarding unused or expired Naproxen Sodium. The product must not be flushed down the toilet or poured down a sink, aligning with environmental protection guidelines for pharmaceutical disposal. If take-back is unavailable, the drug should be mixed with an undesirable substance before being sealed and placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Israel

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z